Grants

View our grants

NIH National Institutes of Health STTR Fast-Track

  • R42HL160384  Endothelialized microfluidic assays for emerging therapies in sickle cell disease (2021)
  • R42HL162214 Microfluidic Technology for Concurrent Assessment of Red Blood Cell Adhesion and Deformability (2022)
  • R42HL182546 Manufacturing and Analytical Validation of the Microfluidic Impedance Red CellAssay (MIRCA) for Commercial Viability (2025)

NSF National Science Foundation

  • 2112202 STTR Phase I: Standardized and reproducible culture and activation of endothelial cells in microfluidic devices for drug screening applications (2021)
  • 2332121 STTR Phase II: Optimized manufacturing and machine learning based automation of Endothelium-on-a-chip microfluidic devices for drug screening applications (2024)

OHIO Third Frontier TVSF Technology Validation and Start-up Fund

  • TECG20211292 Enabling long-term optimal culture of endothelial cells in microfluidic diagnostic devices (2021)
  • TECG20235486 Rapid Hemoglobin-Oxygen Dissociation Assay (RHODA) for red blood cell health and disease (2023)

Signup for News & Updates